The agency stressed the material is inactivated and that the findings "do not represent actual virus that may be a risk to consumers," but it's continuing to study the issue.
Public health authorities are investigating reports of counterfeit injections sickening 19 people across nine states. Experts say getting bona fide Botox starts with finding a trustworthy provider.
At issue in the case is more than abortion rights. It's the entire structure of the FDA's regulatory power to approve drugs and continually evaluate their safety.
At issue is the FDA's regulatory power to approve drugs and continually evaluate their safety — a system that until now has been widely viewed as the gold standard for both safety and innovation
The popular weight-loss drug can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, the FDA said.
The brands of cinnamon are typically sold at discount retailers, such as Save a Lot, Family Dollar and Dollar Tree. The alert follows the recalls of 3 brands of cinnamon-flavored applesauce pouches.
The FDA will soon move to ban formaldehyde in hair-straightening products. It's more than a decade after research raised alarms about health risks and other worrying chemicals remain in the products.
Ketamine, approved as an anesthetic in 1970, is emerging as a major alternative mental health treatment. But more than 500 clinics have popped up with little regulation, and treatment varies widely.
The Food and Drug Administration's authorization of Florida's plan to import prescription medicines from Canada is a first. But the state still has hurdles to clear before imports could begin.
In early December, the Food and Drug Administration approved a gene-editing treatment for sickle cell disease, the first for any illness. One patient helped pave the way.
Thousands of fake units of the drug have been seized by the FDA, which is working alongside the manufacturer to test the counterfeit products for safety concerns.
Administration officials indicated Wednesday the process will continue into next year, targeting March to implement the rule, according to an updated regulatory agenda posted online.
Eli Lilly said the obesity medicine, which helped adults in clinical studies lose about 20% of their body weight, will be available in the U.S. by the end of the year. The list price will be $1,060.
The most popular brands of e-cigarettes among underage smokers are illegal disposables, specifically Elf Bar/EB Designs (56.7%) and Esco Bars (21.6%), according to this year's National Youth Tobacco Survey.